BARRIE, Ontario, June 18, 2020 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation and derivative products, today announced its financial results for the three months ended March 31, 2020. The Company also provided an update on the build out of its global Good Manufacturing Practices (“GMP”) certified production platforms and new international medicinal, wellness and adult use-recreational revenue streams.
To read the full press release from MediPharm Labs Corp., click here.
This headline brief is meant to help you stay on the pulse of your favorite cannabis-related companies. Sometimes, just figuring out which marijuana stocks may be moving can be one of the toughest parts of trading and investing in them.
Every day, The Daily Marijuana Observer seeks to keep stakeholders informed with as much of the latest news possible to keep you informed of any catalysts that may impact the companies you care about. Be sure to subscribe to cannabis stock updates here so you never miss a thing.
Get Real-Time Updates from MJobserver.com